<?xml version="1.0" encoding="UTF-8"?>
<p>SARS-CoVs belongs to a global family of viruses causing respiratory disease and influenza-like symptoms such as fever, muscle pain, sore throat, headache, and cough.
 <sup>
  <xref rid="bibr19-0300060520949077" ref-type="bibr">19</xref>
 </sup>
 <xref ref-type="fig" rid="fig3-0300060520949077">Figure 3</xref> highlights the onset and progression of SARS-CoV-1, MERS-CoV, and SARS-CoV-2 infection. The first case of SARS-CoV-1, reported in China, resulted in an outbreak that caused hundreds of deaths and thousands of infected cases in the early 2000s.
 <sup>
  <xref rid="bibr20-0300060520949077" ref-type="bibr">20</xref>
 </sup> A pneumonia-like syndrome (MERS) was first discovered in Saudi Arabia and then spread to several countries, where it incurred a mortality rate of about 3% to 6%. Marra 
 <italic>etÂ al</italic> (21) observed that the MERS mortality rate increased with age and was as high as 43% to 55% in people older than 60 years. In December 2019, SARS-CoV-2, caused an outbreak in China and then spread worldwide. The resulting disease (COVID-19) is a serious threat mostly in people with compromised immune systems or underlying conditions such as lung disease, diabetes mellitus, and human immunodeficiency virus infection.
 <sup>
  <xref rid="bibr22-0300060520949077" ref-type="bibr">22</xref>
 </sup>
</p>
